Regulators Warn Thailand Over Drug Pricing Policy
European Commission regulators have warned the government of Thailand over its use of compulsory licenses for certain medicines, claiming that the country's pricing policy may violate the rights of European patent...To view the full article, register now.
Already a subscriber? Click here to view full article